1-12 of 12
Francisco J. Esteva
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-165: Personalized prognostic prediction models for breast cancer recurrence and survival incorporating multidimensional data

Free
Xifeng Wu, Yuanqing Ye, Carlos H. Barcenas, Wong-Ho Chow, Qing H. Meng, Mariana Chavez Mac Gregor, Michelle Hildebrandt, Hua Zhao, Xiangjun Gu, Yang Deng, Elizabeth A. Wagar, Francisco J. Esteva, Debu Tripathy, Gabriel N. Hortobagyi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): LB-165.
https://doi.org/10.1158/1538-7445.AM2017-LB-165
Published: 01 July 2017
View article titled, Abstract LB-165: Personalized prognostic prediction models for breast cancer recurrence and survival incorporating multidimensional data
Journal Articles

Abstract 5469: Trastuzumab resistant HER2+ breast cancer cells retain sensitivity to poly (ADP-ribose) polymerase (PARP) inhibition

Free
Monica E. Wielgos, Tiffiny Cooper, Andres Forero, James A. Bonner, Francisco J. Esteva, C K. Osborne, Rachel Schiff, Albert F. LoBuglio, Eddy S. Yang
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5469.
https://doi.org/10.1158/1538-7445.AM2014-5469
Published: 01 October 2014
View article titled, Abstract 5469: Trastuzumab resistant HER2+ breast cancer cells retain sensitivity to poly (ADP-ribose) polymerase (PARP) inhibition
Journal Articles

Abstract 1619: ERK-targeted therapy suppresses tumorigenicity in ovarian clear cell carcinoma and is modulated by ERK-binding protein PEA-15

Free
Tetsuro Oishi, Chandra Bartholomeusz, Anna Kazansky, Ugur Akar, Savitori Krishunamurthy, Francisco J. Esteva, Hiroaki Itamochi, Naoto T. Ueno
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1619.
https://doi.org/10.1158/1538-7445.AM10-1619
Published: 15 April 2010
View article titled, Abstract 1619: ERK-targeted therapy suppresses tumorigenicity in ovarian clear cell carcinoma and is modulated by ERK-binding protein PEA-15
Journal Articles

Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin

Free
Xiaoping Huang, Lizhi Gao, Shuiliang Wang, James L. McManaman, Ann D. Thor, XiaoHe Yang, Francisco J. Esteva, Bolin Liu
Journal: Cancer Research
Cancer Res (2010) 70 (3): 1204–1214.
https://doi.org/10.1158/0008-5472.CAN-09-3321
Published: 31 January 2010
View article titled, Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin
Open the PDF for Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin in another window
Includes: Supplementary data
Journal Articles

The dual EGFR/HER-2 kinase inhibitor lapatinib induces apoptosis and potentiates anti-IGF-IR therapy in trastuzumab-resistant breast cancer cells

Free
Rita Nahta, Linda Xh Yuan, Francisco J. Esteva
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1116.
Published: 15 April 2006
View article titled, The dual EGFR/HER-2 kinase inhibitor lapatinib induces apoptosis and potentiates anti-IGF-IR therapy in trastuzumab-resistant breast cancer cells
Journal Articles

Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma.

Free
Hiroaki Itamochi, Junzo Kigawa, Yasunobu Kanamori, Tetsuro Oishi, Chandra Bartholomeusz, Rita Nahta, Francisco J. Esteva, Nour Sneige, Naoki Terakawa, Naoto T. Ueno
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1289–1290.
Published: 15 April 2006
View article titled, Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma.
Journal Articles

Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells

Free
Rita Nahta, Linda X.H. Yuan, Bing Zhang, Ryuji Kobayashi, Francisco J. Esteva
Journal: Cancer Research
Cancer Res (2005) 65 (23): 11118–11128.
https://doi.org/10.1158/0008-5472.CAN-04-3841
Published: 01 December 2005
View article titled, Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells
Open the PDF for Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells in another window
Journal Articles

Bcl-2 Antisense Oligonucleotide Overcomes Resistance to E1A Gene Therapy in a Low HER2-Expressing Ovarian Cancer Xenograft Model

Free
Chandra Bartholomeusz, Hiroaki Itamochi, Linda X.H. Yuan, Francisco J. Esteva, Christopher G. Wood, Naoki Terakawa, Mien-Chie Hung, Naoto T. Ueno
Journal: Cancer Research
Cancer Res (2005) 65 (18): 8406–8413.
https://doi.org/10.1158/0008-5472.CAN-05-1754
Published: 15 September 2005
View article titled, Bcl-2 Antisense Oligonucleotide Overcomes Resistance to E1A Gene Therapy in a Low HER2-Expressing Ovarian Cancer Xenograft Model
Open the PDF for Bcl-2 Antisense Oligonucleotide Overcomes Resistance to E1A Gene Therapy in a Low HER2-Expressing Ovarian Cancer Xenograft Model in another window
Journal Articles

Serum glycoproteomics in breast cancer using isotope-coded affinity tags

Free
Francisco J. Esteva, Bing Zhang, David H. Hawke, Gabriel N. Hortobagyi, Ryuji Kobayashi
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 736.
Published: 01 May 2005
View article titled, Serum glycoproteomics in breast cancer using isotope-coded affinity tags
Journal Articles

P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells

Free
Rita Nahta, Takeshi Takahashi, Naoto T. Ueno, Mien-Chie Hung, Francisco J. Esteva
Journal: Cancer Research
Cancer Res (2004) 64 (11): 3981–3986.
https://doi.org/10.1158/0008-5472.CAN-03-3900
Published: 01 June 2004
View article titled, P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells
Open the PDF for P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells in another window
Journal Articles

The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells

Free
Rita Nahta, Mien-Chie Hung, Francisco J. Esteva
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2343–2346.
https://doi.org/10.1158/0008-5472.CAN-03-3856
Published: 01 April 2004
View article titled, The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells
Open the PDF for The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells in another window
Journal Articles

PTEN activation contributes to tumor inhibition by trastuzumab and loss of PTEN predicts trastuzumab resistance in patients.

Free
Keng-Hsueh Lan, Yoichi Nagata, Xiaoyan Zhou, Francisco J. Esteva, Aysegul A. Sahin, Kristine S. Klos, Brett P. Monia, Nina Nguyen, Gabriel N. Hortobagyi, Mien-Chie Hung, Dihua Yu
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 569.
Published: 01 April 2004
View article titled, PTEN activation contributes to tumor inhibition by trastuzumab and loss of PTEN predicts trastuzumab resistance in patients.